肥満患者の麻酔

出版社: 金芳堂
著者:
発行日: 2018-11-15
分野: 臨床医学:外科  >  麻酔科学/ペイン
ISBN: 9784765317603
電子書籍版: 2018-11-15 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

7,260 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

7,260 円(税込)

目次

  • 1章 肥満とその病態生理
     1 肥満の定義と患者の動向
     2 肥満による心血管系の変化
     3 肥満による呼吸機能の変化
     4 肥満と閉塞性睡眠時無呼吸
     5 腎機能の変化
     6 消化管および代謝の変化
     7 血液の変化
     8 心理状態

    2章 術前評価と管理
     1 術前評価
     2 心機能評価
     3 気道の評価
     4 術前内科管理
     5 抗血栓療法
     6 物品管理

    3章 術中管理
     1 前投薬および絶飲食
     2 手術室セッティング,モニタリング
     3 全身麻酔導入
     4 薬剤投与量
     5 術中体位
     6 循環管理(輸液管理)
     7 呼吸管理
     8 体温管理
     9 血管確保
     10 気腹状態での変化
     11 覚醒・抜管
     12 DVTとPTE
     13 区域麻酔と超音波の活用

    4章 術後管理
     1 術後鎮痛
     2 合併症とその対策
     3 肥満手術とERAS

    5章 肥満手術

    6章 帝王切開術

    7章 小児

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 肥満とその病態生理

P.10 掲載の参考文献
1) Tokunaga K, et al. Ideal body weight estimated from the body mass index with the lowest morbidity. Int J Obes 1991 ; 15 : 1-5.
2) 吉池信男ら : Body Mass Indexに基づく肥満の程度と糖尿病, 高血圧, 高脂血症の危険因子との関連-多施設共同研究による疫学的検討. 肥満研究 2000 ; 6 : 4-17.
3) 日本肥満学会肥満症診断基準検討委員会 ; 松澤佑次ら : 新しい肥満の判定と肥満症の診断基準. 肥満研究 2000 ; 6 : 18-28.
4) 日本肥満学会肥満症ガイドライン作成委員会 : 肥満症治療ガイドライン 2006. 肥満研究 2006 ; 12 (臨増) : 10-15.
5) 日本肥満学会肥満症ガイドライン作成委員会 : 肥満症治療ガイドライン 2016. ライフサイエンス出版, 巻頭図表xii.
6) Noseda A, et al. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Potential for weaning from continuous positive airway pressure. Chest 1996 ; 109 (1) : 138-143.
9) Chen J, et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004 ; 140 (3) : 167-174.
10) Praga M, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001 ; 16 (9) : 1790-1798.
11) 平成28 年度厚生労働科学研究費補助金難治性疾患等政策研究事業食欲中枢異常による難治性高度肥満症の実態調査報告書
12) Saiki A, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes 2005 ; 29 (9) : 1115-1120.
13) McGavock JM, et al. American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited. Ann Intern Med 2006 ; 144 (7) : 517-524.
P.17 掲載の参考文献
1) Bernstein DP. Cardiovascular physiology. In Morbid Obesity : peri-operative Management, 2nd ed. Alvarez A, et al, pp1-18. Cambridge : Cambridge University Press, 2010.
2) Lauer MS, et al. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991 ; 266 : 231-236.
4) Satish K, et al. Obesity and the Risk of Heart Failure. N Engl J Med 2002 ; 347 : 305-313.
8) Pritchett AM, et al. Left atrial volume as an index of left atrial size : a population-based study. J Am Coll Cardiol 2003 ; 41 : 1036-1043.
9) Alpert MA, et al. The electrocardiogram in morbid obesity. Am J Cardiol 2000 ; 85 : 908-910.
12) Perra O, et al. Early treatment of obstructive apnoea and stroke outcome : a randomised controlled trial. Eur Respir J 2011 ; 37 : 1128-1136.
15) Alpert MA. Obesity cardiomyopathy : Pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001 ; 321 : 225-236.
17) Calle EE, et al.Body-mass index and mortality in a prospective cohort of U. S. adults. N Engl J Med 1999 ; 341 : 1097-1105.
20) Akinnusi M, et al. Impact of obesity on intensive care morbidity and mortality : A meta-analysis. Crit Care Med 2008 ; 36 : 151-158.
22) Adams JP, et al. Obesity in anaesthesia and intensive care. Br J Anaesth 2000 ; 85 : 91-108.
23) DeMaria EJ, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg 2007 ; 246 : 578-582.
P.24 掲載の参考文献
1) Juvin P, et al. Difficult tracheal intubation is more common in obese than in lean patient. Anesth Analg 2003 ; 97 : 595-600.
2) Weiner P, et al. Influence of excwssive weight loss after gastroplasty for morbidly obesity on respiratory muscle performance. Thorax 1998 ; 53 : 34-42.
3) Damia G, et al. Perioperative changes in functional residual capacity in morbidly obese patients. Br J Anaesth 1988 ; 60 : 574-578.
4) Hedenstierna G, et al. Functional residual capacity, thoracoabdominal dimensions, and central blood volume during general anesthesia with muscle paralysis and mechanical ventilation. Anesthesiology 1985 ; 62 : 247-254.
5) Carroll D. A peculiar type of cardiopulmonary failure associated with obesity. Am J Med 1996 ; 21 : 819-824.
6) Brodsky JB, et al. Morbid obesity and tracheal intubation. Anesth Analg 2002 ; 94 : 732-736.
7) Benumof J, et al : Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1mg/kg intravenous succinylcholine Anesthesiology 1997 ; 87 : 979-982.
9) Schwartz AR, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991 ; 44 : 494-498.
10) 佐藤誠 : 日本人の睡眠時無呼吸症候群. 睡眠時呼吸障害update. 日本評論社, pp101-108, 2002.
11) 磯野史朗ら : 肥満患者における睡眠時無呼吸の病態生理. 睡眠医学 2008 ; 2 : 343-348.
12) Tahiri S, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004 ; 1 : e62.
14) Perra O, et al. Early treatment of obstructive apnoea and stroke outcome : a randomised controlled trial. Eur Respir J 2011 ; 37 : 1128-1136.
16) Jokic R, et al. Ventilatory resonses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Throrax 2000 ; 55 : 940-945.
P.35 掲載の参考文献
3) Changnac A, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003 ; 14 : 1480-1486.
5) Liu Y, et al. Cephalometric comparisons between Chinese and Caucasian patients with obstructive sleep apnea. Am J Orthod Dentofacial Orthop 2000 ; 117 (4) : 479-485.
6) 日本腎臓学会編. CKD診療ガイド 2012. 東京医学社, 2012.
6) Young T, et al. The occurrence of sleep-disordered breathing among middleaged adults. N Engl J Med 1993 ; 328 : 1230-1235.
7) Chen J, et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004 ; 140 : 167-174.
8) Arand D. The clinical use of the MSLT and MWT. Sleep 2005 ; 28 (1) : 123-144.
8) Wang Y, et al. Association between obesity and kidney disease : a systematic review and meta-analysis. Kidney Int 2008 ; 73 : 19-33.
10) Nakano H, et al. Effect of body mass index on overnight oximetry for the diagnosis of sleep apnea. Respir Med 2004 ; 98 : 421-427.
11) Collop NA, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007 ; 3 : 737-747.
12) American Academy of Sleep Medicine : International classification of sleep disorders, 3rd ed, American Academy of Sleep Medicine, Darien, IL, 2014.
13) 日本睡眠学会エキスパートコンセンサス 2 (EC2) (http://jssr.jp/data/pdf/EC2.pdf, Accessed in Sept.2017)
16) Saiki A, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes 2005 ; 29 : 1115-1120.
16) Lockhart EM, et al. Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort. Sleep Med 2013 ; 14 (5) : 407-415.
17) Shepard JW Jr. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992 ; 13 (3) : 437-458.
19) Mokhlesi B, et al. Obestiy hypoventilation syndrome : prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007 ; 11 (2) : 117-124.
P.43 掲載の参考文献
1) 坂井建雄. 初心者のための腎臓の構造. 日腎会誌 2001 ; 43 : 572-579.
P.52 掲載の参考文献
2) Chisholm J, et al. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery. Surg Obes Relat Dis 2012 ; 8 : 416-422.
4) 矢部大介ら. 糖尿病におけるインクレチンの分泌と作用-日本人のインクレチン血中濃度を踏まえて. 医学のあゆみ 2010 ; 223 : 393-398.
・ 日本糖尿病学会. 糖尿病治療ガイド 2016-2017
・ 日本肥満学会. 肥満症診療ガイドライン 2016
・ 日本肥満症治療学会. 肥満症の総合的治療ガイド
・ 佐々木章, 笠間和典編. 肥満・糖尿病の外科治療. メディカ出版, 2017
・ 肥満と消化器疾患. 臨牀消化器内科, Vol. 28, No. 12, 2013
P.55 掲載の参考文献
4) Shimomura I, et al. Enhanced expression of PAI-1 in visceral fat : possible contributor to vascular disease in obesity. Nat Med 1996 ; 2 : 800-803.
5) Alessi MC, et al. Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort. Thromb Haemost 2011 ; 106 : 416-422.
6) Eckel RH, et al. American Heart Association call to action : obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998 ; 97 : 2099-2100.
9) Blaszyk H, et al. Factor V leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg 2000 ; 135 : 1410-1413.
10) Tsai AW, et al. Cardiovascular risk factors and venous thromboembolism incidence : the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002 ; 162 : 1182-1189.
P.61 掲載の参考文献
1) 日本肥満症治療学会治療ガイドライン委員会. 肥満症の総合的治療ガイド. コンパス. 2013.
2) 佐々木章ら (編). 手術テクニックからチーム医療の実際まで 肥満・糖尿病の外科治療. メディカ出版. 2017
2) 堀川直史ら. 肥満患者の心理の特徴. 日本肥満症治療学会メンタルヘルス部会 (編著). 肥満症治療に必須な心理的背景の把握と対応~内科的・外科的治療の効果を上げるために~. コンパス. 2016. 12.
3) 林果林ら. 肥満症患者の心理的側面の特徴-ロールシャッハ変数の比較分析から-. 心身医 2016 ; 56 : 920-930.
4) Yu ZB, et al. Intelligence in relation to obesity : a systematic review and meta-analysis. Obes Res 2010 ; 11 : 656-670.
6) 筒井末春ら. 一般心理療法. 新心身医学入門. 南山堂, 1996. 136.

2章 術前評価と管理

P.71 掲載の参考文献
1) 日本肥満学会編集. 肥満症診療ガイドライン 2016. ライフサイエンス出版株式会社. 2016年.
3) メタボリックシンドローム診断基準検討委員会. メタボリックシンドロームの定義と診断基準. 日本内科学会雑誌. 2005 ; 94 : 794-809.
4) Shah A, et al. Managing cardiometabolic risk. An evolving approach to patient care. J Parenter Enteral Nutr 2008 ; 32 : 638-644.
5) Laurent G, et al. Perioperative outcomes among Patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 2010 ; 113 : 859-872.
6) Flegal KM, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002 ; 288 : 1723-1727.
8) Mokdad AH, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003 ; 289 : 76-79.
12) Pelosi P, et al. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg 1998 ; 87 : 654-660.
14) Alpert MA. Obesity cardiomyopathy : pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001 ; 321 : 225-236.
15) Lauer MS, et al. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991 ; 266 : 231-236.
18) Hampel H, et al. Meta-analysis : obesity and the risk for gastroesophageal reflux disease and its complications. Ann Int Med 2005 ; 143 : 199-211.
19) Jean J, et al. The risk of pulmonary aspiration in patients after weight loss due to bariatric surgery. Aneth Analg 2008 ; 107 : 1257-1259.
20) Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Int Med 1993 ; 119 : 1029-1035.
24) Collazo-Clavell ML, et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc 2006 ; 81 : S11-7.
25) Siyam MA, et al. Difficult endotracheal intubation in patients with sleep apnea syndrome. Aneth Analg 2002 ; 95 : 1098-1102.
26) Neligan PJ, et al. Obstructive sleep apnea is not a risk factor for difficult intubation in morbidly obese patients. Aneth Analg 109 : 1182-1186.
27) Catheline JM, et al. Preoperative cardiac and pulmonary assessment in bariatric surgery. Obe Surg 2008 ; 18 : 271-277.
30) Smetana GW, et al. The case against routine preoperative laboratory testing. Med Clin North Am 2003 ; 87 : 7-40.
31) Cawley J, et al. Predicting complications after bariatric surgery using obesity-related co-morbidities. Obes Surg 2007 ; 17 : 1451-1456.
32) Waller WE, et al. Predictors of in-hospital postoperative complications among adults undergoing bariatric procedures in New York state, 2003. Obes Surg 2006 ; 16 : 702-708.
P.80 掲載の参考文献
2) Gami AS, et al. Metabolic syndrome and risk of incident cardiovascular events and death : a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007 ; 49 : 403-414.
3) Lee TH, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999 ; 100 : 1043-1049.
4) Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 ; 130 : 2215-2245.
7) Hlatky MA, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989 ; 64 : 651-654.
8) Goldman L, et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class : advantages of a new specific activity scale. Circulation. 1981 ; 64 : 1227-1234.
P.88 掲載の参考文献
1) Frerk C, et al. Difficult airway society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth 2015 ; 115 : 827-848.
4) Isono S, et al. Pharyngeal patency in response to advancement of the mandible in obese anesthetized persons. Anesthesiology 1997 ; 87 : 1055-1062.
5) Brodsky JB, et al. Morbid obesity and tracheal intubation. Anesth Analg 2002 ; 94 : 732-736.
7) Leoni A, et al. Difficult mask ventilation in obese patients : analysis of predictive factors. Minerva Anestesiol. 2014 ; 80 : 149-157.
P.96 掲載の参考文献
1) Linde JA, et al. The impact of self-efficacy on behavior change and weight change among overweight participants in a weight loss trial. Health Psychol 2006 ; 25 (3) : 282-291.
2) 日本肥満学会編. 肥満症診療ガイドライン 2016
3) Fagard RH. Physical activity in the prevention and treatment of hypertension in the obese. Med Sci Sports Exerc 1999 ; 31 (11) : S624-630.
5) 小山朝一ら : ロールシャッハ・テストを用いた肥満症患者の性格特性分析 : ハイラムダスタイルについて. 肥満研究, 2009 ; 15 (1) : 39-44.
6) Kalarchian MA, et al. Psychiatric disorders among bariatric surgery candidates : relationship to obesity andfunctional health status. Am J Psychiatry 2007 ; 164 (2) : quiz 374.
8) 糖尿病専門医研修ガイドブック 改訂第7版 日本糖尿病学会専門医取得のための研修必携ガイド
9) Lamon-Favas S, et al. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996 ; 16 (12) : 1509-1515.
11) 平成2年版国民栄養の現状-昭和63年国民栄養調査成績-
12) 日本高血圧学会高血圧治療ガイドライン作成委員会編. 高血圧治療ガイドライン 2014
13) Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 ; 130 (24) : e278-333.
14) Yamashita S, et al. Studies on the impaired metabolism of uric acid in obese subjects : marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 1986 ; 10 (4) : 255-264.
17) Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005 ; 115 (5) : 897-909 ; quiz 910.
P.103 掲載の参考文献
1) 黒岩政之ほか : 2003年周術期肺血栓塞栓症発症アンケート調査結果調査結果からみた本邦における発症頻度とその特徴- (社) 日本麻酔科学会肺塞栓症研究ワーキンググループ報告-. 麻酔 2006 ; 55 : 1031-1038.
4) 黒岩政之 : 肺血栓塞栓症. 麻酔 2011 ; 60 : S55-S68.
6) Siddiqui AU, et al : Pulmonary embolism as a consequence of applying sequential compression device on legs in a patient asymptomatic of deep vein thrombosis. Anesthesiology 2000 ; 92 : 880-882.
13) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会 (編) : 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン ダイジェスト版. (http://www.jsth.org/com/c1/c1-7/)
15) Scholten DJ, et al : A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002 ; 12 : 19-24.
19) Buckley LF, et al : Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age. Clin Cardiol 2017 ; 40 : 46-52.
22) Rafferty JA, et al : Acute pulmonary emboli in a patient on long-term dabigatran therapy. Ann Pharmacother 2013 ; 47 (4) : e20.
23) Safouris A, et al : Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient. J Neurol Sci 2014 ; 346 : 366-367.

3章 術中管理

P.112 掲載の参考文献
1) Maltby JR, et al. Drinking 300mL of clear fluid two hours before surgery has no effect on gastric fluid volume and pH in fasting and non-fasting obese patients. CanJ Anaeth 2004 ; 51 : 111-115.
P.117 掲載の参考文献
P.122 掲載の参考文献
1) Brodsky JB, et al. Morbid obesity and tracheal intubation. Anesth Analg 2002 ; 94 : 732-736.
2) Nimmagadda U, et al. Preoxygenation with tidal volume and Deep breathing techniques : the impact of duration of breathing and fresh gas flow. Anes Analg 2001 ; 92 : 1337-1341.
4) Heinrich S, et al. Benefits of heated and humidified high flow nasal oxygen for preoxygenation in morbidly obese patients undergoing bariatric surgery : a randomized controlled study. J Obes Bariatrics 2014 ; 1 (1) : 7.
P.132 掲載の参考文献
1) Bouillen T, et al. Dose size matter? Anesthesiology 1998 ; 89 : 557-560.
2) Green B, et al. What is the best size descriptor to hse for pharmacokinetic studies in the obese? Br J Clin Pharmacol 2004 ; 58 : 119-133.
4) Ingrande J, et al. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth 2010 ; 105 Suppl 1 : i16-23.
7) Servin F, et al. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 1993 ; 78 : 657-665.
8) 五十嵐妙ら. 高度肥満患者にプロポフォール静脈麻酔を行い術中覚醒を来した2症例. 麻酔 2002 ; 51 : 1243-1247.
13) Bouillon T, et al. Does size matter? Anesthesiology 1998 ; 89 : 557-560.
15) Egan TD, et al. Remifentanyl pharmacokinetics in obese vs lean patients. Anesthesiology 1998 ; 89 : 562-573.
20) Bilotta F, et al. Early postoperative congnitive recovery and gas exchange patterns after balanced anesthesia with sevoflurane or desuflurane in overweight and obese patients undergoing craniotomy : a prospective randomized trial. J Neurosurg Anesthesiol 2009 ; 21 : 207-213.
21) 成田浩江ら. 肥満患者におけるデスフルラン麻酔の有用性の検討. MASUI 2018 ; 67.
22) Lesson S, et al. Hypoventilation after inhaled anesthesia results in reanesthetization. Anesth Analg 2014 ; 119 : 829-835.
23) De Oliveira GS Jr, et al. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery : a randomized double-blinded placebocontrolled trial. Obes Surg 2014 ; 24 : 212-218.
24) Kaba A, et al. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology 2007 ; 106 : 11-18.
P.140 掲載の参考文献
2) Brown BR. Anesthesia and the Obese Patient. Contemporary Anesthesia Practice Series. Philadelphia, FA Davis, 1982, p26.
4) Warner MA, et al. Ulner neuropathy : incidence, outcome, and risk factors in sedated or anesthetized patients. Anesthesiology 1994 ; 81 : 1332-1340.
5) Yasin A, et al. Bilateral sciatic nerve palsy following a bariatic operation. Obes Surg 2007 ; 17 : 983-985.
8) Garcia RM, et al. The obesity supine sudden death syndrome in the perioperative patient. Crit Care & Shock 2014 ; 4 : 82-84.
11) Brodsky JB, et al. Morbid Obesity and the Prone Position : A Case Report. J Clin Anesth 2001 ; 13 : 138-140.
P.145 掲載の参考文献
1) Donohoe CL, et al. Perioperative evaluation of the obese patient. J Clin Anesth 2011 ; 23 : 575-586.
3) Minoz JL, et al. Goal-Directed Fluid Therapy on Laparscopic Sleeve Gastrectomy in Morbidly Obese Patients. Obes Surg 2016 ; 26 : 2648-2653.
5) Demirel I, et al. Efficacy of Goal-Directed Fluid Therapy via Pleth Variability Index During Laparoscopic Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients. Obes Surg 31 July 2017 Published Online.
P.147 掲載の参考文献
P.154 掲載の参考文献
1) Pelosi P, et al. Positive end-expiratory pressure improves respiratory function in obvese but not normal subjects during anesthesia and parelysis. Anesthesiology 1999 ; 91 : 1221-1223.
4) Ezri T, et al. The endtracheal tube moves more often in obese patients under laparoscopy compared with open abdominal surgery. Anesth Analg 2003 ; 96 : 278-282.
5) Saranita J, et al. Elevated liver enzymes as an operative complication of gastric bypass surgery. Obes Surg 2003 ; 13 : 347-349.
6) Nguyen NH, et al. Effect of prolonged pneumoperitoneum on intraoperative urine outpt during laparoscopic gastric bypass. J Am Coll Surg 2002 ; 195 : 476-483.
7) Liaurado S, et al. Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery. Anesthesiology 2012 ; 117 : 93-98.
P.158 掲載の参考文献
P.161 掲載の参考文献
2) Juhan-Vague I, et al. The insulin resistance syndrome : implications for thrombosis and cardiovascular disease. Pathophysiol Haemost Thromb 2002 ; 32 (5-6) : 269-273.
3) Blaszyk H, et al. Factor V Leiden and Morbid Obesity in Fatal Postoperative Pulmonary Embolism. Arch Surg 2000 ; 135 : 1410-1413.
5) Venous Thromboembolism Prevention Quality Standard. National Institute for Health and care Exellence (NICE), 2010. https://www.nice.org.uk/guidance/qs3
6) Gould MK, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 ; 141 (2 Suppl) : e227S-277S.
P.165 掲載の参考文献
4) Wallance DH, et al. Indirect sonographic guidance for epidural anesthesia in obese pregnant patients. Reg Anesth 1992 ; 17 : 233-236.
5) Hood D, et al. Anesthetic and obstetric outcome in morbidly obese parturients. Anesthesiology 1993 ; 79 : 1210-1218.
6) Perlow JH, et al. Massive maternal obesity and perioperative cesarean morbidity. Am J obstet Gynecol 1994 ; 170 : 560-565.
7) Jones N, et al. Post dural puncture headache in morbidly obese patients. Can J Anaesth 2006 ; 53 : 26343.
8) Grau T, et al. The lumbar epidural space in pregnancy : visualization by ultrasonography. Br J Anaesth 2001 ; 86 : 798-804.
9) Escovedo HP, et al. Ultrasound-guided nerve blocks. Rev Bras Anestesiol 2007 ; 57 : 106-123.

4章 術後管理

P.173 掲載の参考文献
1) Graves DA, et al : Morphine requirements using patient-controlled analgesia : influence of diurnal variation and morbid obesity. Clin Pharm 1983 ; 2 : 49-53.
3) Besson JM : The neurobiology of pain. Lancet 1999 ; 353 : 1610-1615.
6) Ogunnaike BO, et al : Anesthetic considerations for bariatric surgery. Anesth Analg 2002 ; 95 : 1793-1805.
8) Harris SI, et al : Parecoxib sodium demonstrates gastrointestinal safety comparable to placebo in healthy subjects. J Clin Gastroenterol 2004 ; 38 : 575-580.
13) Elia N, at al : Ketamine and postoperative pain--a quantitative systematic review of randomised trials. Pain 2005 ; 113 : 61-70.
14) Zakine J, et al : Postoperative ketamine administration decreases morphine consumption in major abdominal surgery : a prospective, randomized, doubleblind, controlled study. Anesth Analg 2008 ; 106 : 1856-1861.
16) Manikian B, et al : Improvement of diaphragmatic function by a thoracic extradural block after upper abdominal surgery. Anesthesiology 1988 ; 68 : 379-386.
17) Pansard JL, et al : Effects of thoracic extradural block on diaphragmatic electrical activity and contractility after upper abdominal surgery. Anesthesiology 1993 ; 78 : 63-71.
20) Charghi R, et al : Patient controlled i.v. analgesia is an acceptable pain management strategy in morbidly obese patients undergoing gastric bypass surgery. A retrospective comparison with epidural analgesia. Can J Anaesth 2003 ; 50 : 672-678.
P.181 掲載の参考文献
10) Huerta S, et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002 ; 6 : 354-358.
13) Tkacova R, et al. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998 ; 98 : 2269-2275.
14) Ebeo CT, et al. The effect of bi-level positive airway pressure on postoperative pulmonary function following gastric surgery for obesity. Respir Med 2002 ; 96 : 672-676.
15) Adams JP, et al. Obesity in anaesthesia and intensive care. Br J Anaesth 2000 ; 85 : 91-108.
16) Eichenberger A, et al. Morbid obesity and postoperative pulmonary atelectasis : an underestimated problem. Anesth Analg 2002 ; 95 : 1788-1792.
17) Kranke P, et al. An increased body mass index is no risk factor for postoperative nausea and vomiting. A systematic review and results of original data. Acta Anaesthesiol Scand 2001 ; 45 : 160-166.
18) Ho KY, et al. Multimodal antiemetic therapy and emetic risk profiling. Ann Acad Med Singapore. 2005 ; 34 : 196-205.
21) Warner MA, et al. Ulnar neuropathy. Incidence, outcome, and risk factors in sedated or anesthetized patients. Anesthesiology 1994 ; 81 : 1332-1340.
24) Hubert HB, et al. Obesity as an independent risk factor for cardiovascular disease : a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983 ; 67 : 968-977.
28) Sauret JM, et al. Rhabdomyolysis. Am Fam Physician 2002 ; 65 : 907-912.
34) Iser I C, et al. Major urologic surgery and rhabdomyolysis in two obese patients. Int J Urol 2003 ; 10 : 558-560.
35) Vanholder R, et al. Rhabdomyolysis. J Am Soc Nephrol 2000 ; 11 : 1553-1561.
36) Abassi ZA, et al. Acute renal failure complicating muscle crush injury. Semin Nephrol 1998 ; 18 : 558-565.
P.190 掲載の参考文献
1) Thorell A, et al. Guidelines for Perioperative Care in Bariatric Surgery : Enhanced Recovery After Surgery (ERAS) Society Recommendations. See comment in PubMed Commons belowWorld J Surg 2016 ; 40 : 2065-2083.
2) Mechanick JI, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. See comment in PubMed Commons belowObesity (Silver Spring) 2009 ; 17 Suppl 1 : S1-70,
4) Mills E, et al. Smoking cessation reduces postoperative complications : a systematic review and meta-analysis. See comment in PubMed Commons belowAm J Med 2011 ; 124 : 144-154.
5) Gustafson UO, et al. Guidelines for perioperative care in elective colonic surgery : Enhanced Recovery After Surgery (ERAS) Society recommendations. Clin Nutr 31 : 783-800.
6) Edholm D, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. See comment in PubMed Commons belowObes Surg 2011 ; 21 : 345-350.
7) Colles SL, et al. Preoperative weight loss with a very-low-energy diet : quantitation of changes in liver and abdominal fat by serial imaging. See comment in PubMed Commons belowAm J Clin Nutr 2006 ; 84 : 304-311.
8) Barnes PJ. Anti-inflammatory actions of glucocorticoids : molecular mechanisms. See comment in PubMed Commons belowClin Sci (Lond) 1998 ; 94 (6) : 557-572.
9) Henzi I, et al. Dexamethasone for the prevention of postoperative nausea and vomiting : a quantitative systematic review. See comment in PubMed Commons belowAnesth Analg 2000 ; 90 : 186-194.
11) Ljungqvist O. Jonathan E. Rhoads lecture 2011 : Insulin resistance and enhanced recovery after surgery. JPEN J Parenter Enteral Nutr 2012 ; 36 : 389-398.
12) de Menezes Ettinger JE, et al. Prevention of rhabdomyolysis in bariatric surgery. See comment in PubMed Commons belowObes Surg 2005 ; 15 (6) : 874-879.
14) Apfel CC, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. See comment in PubMed Commons belowBr J Anaesth 2012 ; 109 (5) : 742-753.
16) Strum EM, et al. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients : a prospective, randomized study. See comment in PubMed Commons belowAnesth Analg 2004 ; 99 : 1848-1853.
18) Futier E, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. See comment in PubMed Commons belowN Engl J Med 2013 ; 369 : 428-437.
20) Baillard C, et al. Postoperative residual neuromuscular block : a survey of management. See comment in PubMed Commons belowBr J Anaesth 2005 ; 95 : 622-626.
26) Wassef M, et al. Feasibility and analgesic efficacy of the transversus abdominis plane block after single-port laparoscopy in patients having bariatric surgery. See comment in PubMed Commons belowJ Pain Res 2013 ; 27 : 837-841.
28) Overby DW, et al. Prevalence of thrombophilias in patients presenting for bariatric surgery. Obes Surg 2009 ; 19 : 1278-1285.
30) Wong DT, et al. A comparison between the Boussignac(TM) continuous positive airway pressure mask and the venturi mask in terms of improvement in the PaO2/F (I) O2 ratio in morbidly obese patients undergoing bariatric surgery : a randomized controlled trial. Can J Anaesth 2011 ; 58 : 532-539.
31) Rennotte MT, et al. Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery. See comment in PubMed Commons belowChest 1995 ; 107 : 367-374.

5章 肥満手術

P.210 掲載の参考文献
1) Scopinaro N. The IFSO and obesity surgery throughout the world. Obes Surg 1998 ; 8 : 3-8.
3) Anderson B, et al. The impact of laparoscopic sleeve gastrectomy on plasma ghrelin levels : a systematic review. Obes Surg 2013 ; 23 : 1476-1480.
6) Kasama K, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass : technique and preliminary results. Obes Surg 2009 ; 19 : 1341-1345.
7) 日本内視鏡下肥満・糖尿病外科研究会 第5回アンケート調査 (2017年)
8) Tagaya N, et al. Evaluation of the excluded stomach by double-balloon endoscopy after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2007 ; 17 : 1165-1170.
9) 日本内視鏡外科学会. 重症肥満に対する外科治療に対する見解 (http://www.jses.or.jp/member/regulation_himan.html)
10) Gastrointestinal Surgery for Severe Obesity. NIH Consensus Statement Online 1991 ; 9 : 1-20.
11) 日本肥満症治療学会 肥満外科治療ガイドライン策定委員会. 日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン 2013.
12) Rubino F, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes : A Joint Statement by International Diabetes Organizations. Diabetes Care 2016 ; 39 : 861-877.
13) American Diabetes Association : Standards of Medical Care in Diabetes-2017. Diabetes Care 2017 ; 40 (Suppl 1) : S1-S135.
14) 日本糖尿病学会 糖尿病診療ガイドライン 2016
19) Adams T, et al : Long-term mortality after gastric bypass surgery. N Eng J Med 2007 ; 357 : 753-761.

6章 帝王切開術

P.227 掲載の参考文献
P.228 掲載の参考文献
1) Whitty RJ, et al. Complications of neuraxial anesthesia in an extreme morbidly obese patient for Cesarean section. Int J Obstet Anesth 2007 ; 16 : 139-144.
2) Hodgkinson R, et al. Caesarean section associated with gross obesity. Br J Anaesth 1980 ; 52 : 919-923.
P.229 掲載の参考文献
1) 日本肥満学会編集. 肥満症診療ガイドライン 2016. ライフサイエンス出版株式会社. 2016年.
2) 日本産科婦人科学会/日本産婦人科医会編集・監修. 産婦人科診療ガイドライン 産科編 2017. p16, 2017年.
3) 厚生労働省. 平成28年「国民健康・栄養調査」の結果 (http://www.mhlw.go.jp/stf/houdou/0000177189.html).
5) Eng M, et al. Respiratory function in pregnant obese women. Am J Obstet Gynecol 1975 ; 123 : 241-245.
7) Maasilta P, et al. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001 ; 120 : 1448-1454.
8) Bende M, et al. Nasal stuffiness during pregnancy. Laryngoscope 1999 ; 109 : 1108-1110.
9) Kowall J, et al. Precipitation of obstructive sleep apnea during pregnancy. Obstet Gynecol 1989 ; 74 : 453-455.
11) Perez-Chada D, et al. Snoring, witnessed sleep apnoeas and pregnancyinduced hypertension. Acta Obstet Gynecol Scand 2007 ; 86 : 788-792.
12) Bourjeily G, et al. Pregnancy and fetal outcomes of symptoms of sleepdisordered breathing. Eur Respir J 2010 ; 36 : 849-855.
18) Weiss JL, et al. Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol 2004 ; 190 : 1091-1097.
19) Veille JC, et al. Obesity, pregnancy, and left ventricular functioning during the third trimester. Am J Obstet Gynecol 1994 ; 171 : 980-983.
23) Nilsson M, et al. Body mass and reflux oesophagitis : an oestrogen-dependentassociation? Scand J Gastroenterol 2002 ; 37 : 626-630.
27) Chu SY, et al. Maternal obesity and risk of cesarean delivery : a metaanalysis. Obes Rev 2007 ; 8 : 385-394.
31) Johnson JW, et al. Excessive maternal weight and pregnancy outcome. Am J Obstet Gynecol 1992 ; 167 : 353-370.
34) Perlow JH, et al. Massive maternal obesity and perioperative cesarean morbidity. Am J Obstet Gynecol 1994 ; 170 : 560-565.
39) Hood DD, et al. Anesthetic and obstetric outcome in morbidly obese parturients. Anesthesiology. 1993 ; 79 : 1210-1218.
40) Hamza J, et al. Parturient's posture during epidural puncture affects the distance from skin to epidural space. J Clin Anesth 1995 ; 7 : 1-4.
44) Hamilton CL, et al. Changes in the position of epidural catheters associated with patient movement. Anesthesiology 1997 ; 86 : 778-784.
45) Modder J, et al. The Centre for Maternal and Child Enquiries (CMACE) and the Royal College of Obstetricians and Gynaecologists (RCOG). CMACE/RCOG Joint Guidline. Management of Women with Obesity in Pregnancy. (https://www.rcog.org.uk/globalassets/documents/guidelines/cmacercogjointguidelinemanagementwomenobesitypregnancya.pdf)
49) Samsoon GL, et al. Difficult tracheal intubation : a retrospective study. Anaesthesia 1987 ; 42 : 487-490.
50) Brock-Utne JG, et al. The effect of metoclopramide on the lower oesophageal sphincter in late pregnancy. Anaesth Intensive Care 1978 ; 6 : 26-29.
51) Coombs DW, et al. Acid-aspiration prophylaxis by use of preoperative oral administration of cimetidine. Anesthesiology 1979 ; 51 : 352-356.
52) Tsueda K, et al. Obesity supine death syndrome : reports of two morbidly obese patients. Anesth Analg 1979 ; 58 : 345-347.
53) Pierin AM, et al. Blood pressure measurement in obese patients : comparison between upper arm and forearm measurements. Blood Press Monit 2004 ; 9 : 101-105.
55) Hogan QH, et al. Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure. Anesthesiology 1996 ; 84 : 1341-1349.
56) Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg 1985 ; 64 : 715-730.
58) Lee Y, et al. Dose requirement of intrathecal bupivacaine for cesarean delivery is similar in obese and normal weight women. Rev Bras Anestesiol 2009 ; 59 : 674-683.
61) Byrne F, et al. The effect of pregnancy on pulmonary nitrogen washout. A study of pre-oxygenation. Anaesthesia 1987 ; 42 : 148-150.
62) Berthoud MC, et al. Effectiveness of preoxygenation in morbidly obese patients. Br J Anaesth 1991 ; 67 : 464-466.
64) Dixon BJ, et al Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients : a randomized controlled study. Anesthesiology 2005 ; 102 : 1110-1115.
66) Cressey DM, et al. Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women. Anaesthesia 2001 ; 56 : 680-684.
67) McClelland SH, et al. Pre-oxygenation and apnoea in pregnancy : changes during labour and with obstetric morbidity in a computational simulation. Anaesthesia 2009 ; 64 : 371-377.
68) Brimacombe J. Acute pharyngolaryngeal oedema and pre-eclamptic toxaemia. Anaesth Intensive Care 1992 ; 20 : 97-98.
72) Mushambi MC, et al. Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia 2015 ; 70 : 1286-1306.
73) Torri G, et al. Wash-in and wash-out curves of sevoflurane and isoflurane in morbidly obese patients. Minerva Anestesiol 2002 ; 68 : 523-527.
74) Juvin P, et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients : a prospective, randomized study. Anesth Analg 2000 ; 91 : 714-719.
75) Pelosi P, et al. Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol 2010 ; 24 : 211-225.
79) Abouleish E, et al. The addition of 0.2 mg subarachnoid morphine to hyperbaric bupivacaine for cesarean delivery : a prospective study of 856 cases. Reg Anesth 1991 ; 16 : 137-140.
80) Edwards LE, et al. Pregnancy complications and birth outcomes in obese and normal-weight women : effects of gestational weight change. Obstet Gynecol 1996 ; 87 : 389-394.
81) 小林隆夫ほか. 産婦人科領域における深部静脈血栓症/肺血栓塞栓症-1991 年から2000年までの調査成績-. 日産婦新生児血液会誌 2005 ; 14 : 1-24.
82) 日本産婦人科医会. 母体安全への提言 2015. (http://www.jaog.or.jp/wp/wpcontent/uploads/2017/01/botai_2015.pdf)
83) 日本ペインクリニック学会・日本麻酔科学会・日本区域麻酔学会合同 抗血栓療法中の区域麻酔・神経ブロックガイドライン作成ワーキンググループ : 抗血栓療法中の区域麻酔・神経ブロックガイドライン. (http://www.anesth.or.jp/guide/pdf/guideline_kouketsusen.pdf)

7章 小児

P.249 掲載の参考文献
1) 日本肥満学会編集. 小児肥満症診療ガイドライン 2017. ライフサイエンス出版. 2017年.
3) 大関武彦. 小児肥満の成因・病態および診断基準. 日本臨牀 2013 ; 71 : 303-309.
4) Baum VC, et al. Anesthesia for genetic, metabolic, and dysmorphic syndromes of childhood. 2nd edition. Lippincott Williams and Wilkins. 2007. 308-309.
5) 上北郁男ら. ダウン症候群患児の麻酔管理. 日小児麻酔会誌 2015 ; 21 : 229-233.
7) 村田光範. 肥満度, BMI, 身長・体重成長曲線, そして子どもの肥満-思春期の子どもの体格評価指数としてのBMIの問題点-. 日成長会誌 2014 ; 20 : 51-64.
8) 日本小児内分泌学会・日本成長学会合同標準値委員会. 日本人小児の体格の評価に関する基本的な考え方. 日成長会誌 2011 ; 17 : 84-99.
9) Wabitsch M. Overweight and obesity in European children : definition and diagnostic procedures, risk factors and consequences for later health outcome. Eur J Pediatr 2000 ; 159 : S8-13.
10) 菊池透ら. 小児肥満の疫学的アプローチ. 肥満研究 2004 ; 10 : 12-17.
11) 日本高血圧学会高血圧治療ガイドライン作成委員会. 高血圧治療ガイドライン 2014. ライフサイエンス出版. 2014年.
14) 小林浩司ら. 小児科領域の症例から学ぶ2型糖尿病清涼飲料水ケトーシス. 小児科診療 2003 ; 66 : 1021-1029.
15) Weiss R, et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005 ; 28 : 902-909.
16) Pashankar DS, et al. Increased prevalence of gastroesophageal reflux symptoms in obese children evaluated in an academic medical center. J Clin Gastroenterol 2009 ; 43 : 410-413.
29) Philippi-Hohne C. Anaesthesia in the obese child. Best Pract Res Clin Anaesthesiol 2011 ; 25 : 53-60.
33) Zwass MS, et al. Induction and maintenance characteristics of anesthesia with desflurane and nitrous oxide in infants and children. Anesthesiology 1992 ; 76 : 373-378.
35) Egan TD, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998 ; 89 : 562-573.
36) Strauss SG, et al. Ventilatory response to CO2 in children with obstructive sleep apnea from adenotonsillar hypertrophy. Anesth Analg 1999 ; 89 : 328-332.
37) Rennotte MT, et al. Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery. Chest 1995 ; 107 : 367-374.
39) Joseph L, et al. High-Flow Nasal Cannula Therapy for Obstructive Sleep Apnea in Children. J Clin Sleep Med 2015 ; 11 : 1007-1010.

最近チェックした商品履歴

Loading...